REVB (STOCKS)
Revelation Biosciences, Inc. Common Stock
$0.761500
+0.036400 (+5.02%)
Prev close: $0.725100
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- James M. Rolke
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3.01M
- Employees
- 9
- P/E (TTM)
- -0.06
- P/B (TTM)
- 0.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.87 | $-0.85 | -0.0234 | -2.76% |
|
Mar 2026 (Q1)
|
$-2.71 | $-1.17 | -1.5370 | -131.03% |
|
Dec 2025 (Q4)
|
$-23.95 | $-3.73 | -20.2168 | -541.54% |
|
Sep 2025 (Q3)
|
$-7.08 | $-5.45 | -1.6332 | -29.98% |